Paul Little
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Financial Officer | $479,226 | $1,592,943 |
| 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Financial Officer | $459,431 | $3,090,335 |
| 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Financial Officer | $441,448 | $1,321,176 |
| 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Financial Officer | $421,051 | $1,057,392 |
| 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Financial Officer | $323,269 | $2,307,958 |
Earnings-call appearances
-
Eledon Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-11
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-03-30
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-14
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-11
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-12
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-03-24
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-12
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-12
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-05-13
Eledon Pharmaceuticals, Inc. (ELDN)